Nuvo is a healthcare technology leader advancing prenatal care with INVU by Nuvo™️, an FDA and CE-approved, AI-driven remote monitoring platform. INVU™️ seamlessly collects vital maternal and fetal biometric data, including fetal heart rate (FHR), maternal heart rate (MHR), and uterine activity. INVU, recognized among TIME’s Best Inventions of 2024, has earned acclaim for its transformative impact on maternal-fetal health monitoring.
INVU enables clinicians to expand care services by offering remote fetal non-stress tests (NSTs). Healthcare providers benefit from streamlined clinical workflows, improved protocol adherence, and the ability to monitor multiple remote NSTs simultaneously. The platform enhances operational efficiency while creating new revenue opportunities and elevating practice prestige.
This innovation allows expecting mothers to do NSTs from home or work, eliminating travel time, waiting room delays, and childcare challenges. INVU gets outstanding reviews from expecting mothers who use it and has been shown to save as much as 12 hours for expecting mothers over the course of a pregnancy.
INVU by Nuvo combines a comfortable wearable sensor band with sophisticated cloud-based processing and dedicated software applications for both mothers and physicians. The platform excels in monitoring high-risk pregnancies that are medically indicated for frequent monitoring, including cases involving hypertension, gestational diabetes, preeclampsia, high BMI, and advanced maternal age. The platform’s remote monitoring capabilities expand access to quality prenatal care, particularly benefiting underserved communities.
The data generated by INVU provides deeper insights into pregnancy health than previously possible. Nuvo is leveraging AI to explore how INVU can help clinicians identify and address complications such as placental insufficiency, intrauterine growth restriction (IUGR), and fetal distress at earlier stages.